Cosette takes aim at Mayne’s pleading in damages case over failed $672M merger


US drug maker Cosette wants to strike out Mayne Pharma’s causation pleading in its suit seeking damages after Cosette allegedly inducing the treasurer to reject their $672 million tie-up.
For information on rights and reprints, contact subscriptions@lawyerly.com.au